MFS New Discovery Fund Class C MNDCX

Morningstar Medalist Rating
  • NAV / 1-Day Return$18.55  /  −2.06%
  • Fund Size$2.0B
  • Adjusted Expense Ratio1.960%
  • Net Expense Ratio1.960%
  • Fee Level: DistributionAverage
  • Share Class TypeLevel Load
  • Morningstar CategorySmall Growth
  • Equity Style Box (Funds)Small Growth
  • Minimum Initial Investment$1,000
  • Investment StatusOpen
  • TTM Yield0.00%
  • Turnover Ratio95%

Morningstar’s Analysis MNDCX

Will MNDCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still a strong small-growth vehicle for the long haul.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

MFS New Discovery’s strengths remain intact, and it retains its Above Average People and Process Pillar ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MNDCX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings19.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Currency Cash CASH_USD

3.1865M
Cash and Equivalents

Ligand Pharmaceuticals Inc

2.6855M
Healthcare

CACI International Inc Class A

2.5853M
Technology

Merit Medical Systems Inc

2.0843M
Healthcare

Element Solutions Inc

1.7937M
Basic Materials

Moog Inc Class A

1.7636M
Industrials

The Chefs' Warehouse Inc

1.7436M
Consumer Defensive

Charles River Laboratories International Inc

1.7436M
Healthcare

Waystar Holding Corp

1.6634M
Healthcare

Finning International Inc

1.6333M
Industrials

Sponsor Center